Éric Lepage

Active 1989–2015

Also published as
Eric Lepage · Eric LePage
70
Papers
21,102
Citations
49
h-index
52
i10-index

Citations

Citations per year for Éric Lepage1988: 1 citations1990: 2 citations1991: 3 citations1992: 2 citations1993: 6 citations1994: 18 citations1995: 20 citations1996: 15 citations1997: 50 citations1998: 62 citations1999: 50 citations2000: 76 citations2001: 105 citations2002: 153 citations2003: 222 citations2004: 201 citations2005: 215 citations2006: 219 citations2007: 238 citations2008: 282 citations2009: 165 citations2010: 208 citations2011: 213 citations2012: 161 citations2013: 128 citations2014: 149 citations2015: 129 citations2016: 82 citations2017: 91 citations2018: 70 citations2019: 267 citations2020: 244 citations2021: 241 citations2022: 130 citations2023: 63 citations2024: 144 citations2025: 51 citations2026: 4 citations1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,526 citing papers, 24.9% of this breakdownFrance: 544 citing papers, 8.9% of this breakdownItaly: 400 citing papers, 6.5% of this breakdownGermany: 376 citing papers, 6.2% of this breakdownUnited Kingdom: 375 citing papers, 6.1% of this breakdownChina: 300 citing papers, 4.9% of this breakdownCanada: 296 citing papers, 4.9% of this breakdownSpain: 232 citing papers, 3.8% of this breakdownSwitzerland: 189 citing papers, 3.1% of this breakdownJapan: 177 citing papers, 2.9% of this breakdownNetherlands: 155 citing papers, 2.5% of this breakdownAustralia: 142 citing papers, 2.3% of this breakdown
0%24.9%Other 23%

Fields

  • Medicine83.8%
  • Biochemistry, Genetics and Molecular Biology8%
  • Immunology and Microbiology3.1%
  • Computer Science1.6%
  • Health Professions1.5%
  • Mathematics0.4%
  • Other1.6%

Topics

  • Lymphoma Diagnosis and Treatment18.5%
  • CNS Lymphoma Diagnosis and Treatment6.4%
  • Viral-associated cancers and disorders4.9%
  • CAR-T cell therapy research4.5%
  • Chronic Lymphocytic Leukemia Research4.4%
  • Cutaneous lymphoproliferative disorders research2.5%
  • Other58.8%

Coauthors

All papers

Open in search
  1. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2002 cited by 5,562

  2. Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'Adulte

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2005 cited by 1,499

  3. Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: a randomized study from the Groupe d'Etude des Lymphomes Folliculaires. Groupe d'Etude des Lymphomes de l'Adulte.

    Authors: , , , , , , , , , - Journal of Clinical Oncology 1997 cited by 641

  4. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study

    Authors: , , , , , , , , , , , - Intensive Care Medicine 2001 cited by 979

  5. Treatment of Acute Hypoxemic Nonhypercapnic Respiratory Insufficiency With Continuous Positive Airway Pressure Delivered by a Face Mask

    Authors: , , , , , , , , , , , , - JAMA 2000 cited by 516

  6. Mortality prediction using SAPS II: an update for French intensive care units

    Authors: , , , , , , , , , - Critical Care 2005 cited by 176

  7. Noninvasive Versus Conventional Mechanical Ventilation

    Authors: , , , , - American Journal of Respiratory and Critical Care Medicine 2001 cited by 489

  8. A Clinical Decision Support System for Prevention of Venous Thromboembolism

    Authors: , , , , - JAMA 2000 cited by 245

  9. A predictive model for aggressive non-Hodgkin's lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - 1993 cited by 3,496

  10. Recombinant Interferon Alfa-2b Combined with a Regimen Containing Doxorubicin in Patients with Advanced Follicular Lymphoma

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1993 cited by 269

  11. Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 1998 cited by 207

  12. p53 gene mutations are associated with poor survival in low and low-intermediate risk diffuse large B-cell lymphomas

    Authors: , , , , , , , , , , , , - Annals of Oncology 2002 cited by 104

  13. Application of Information Technology: A UMLS-based Knowledge Acquisition Tool for Rule-based Clinical Decision Support System Development

    Authors: , , , , - Journal of the American Medical Informatics Association, J. Am. Medical Informatics Assoc. 2001 cited by 96

  14. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome

    Authors: , , , , , , , , , , - Blood 2005 cited by 497

  15. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).

    Authors: , , , , , , , , , , , , - 1998 cited by 438

  16. Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

    Authors: , , , , , , , , , , , - Annals of Oncology 2000 cited by 206

  17. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma

    Authors: , , , , , , , - Blood 2000 cited by 165

  18. Primary Mediastinal Large B-Cell Lymphoma

    Authors: , , , , , , , , , , , , - The American Journal of Surgical Pathology 1996 cited by 229

  19. Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients

    Authors: , , , , , , , , , , , - Intensive Care Medicine 1999 cited by 213

  20. Characteristics and Outcome of Diffuse Large B-Cell Lymphoma in Hepatitis C Virus–Positive Patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte Programs

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2006 cited by 169

  21. Quality indicators from laboratory and radiology information systems

    Authors: , , , , , , , , - Studies in health technology and informatics, MedInfo 2015 cited by 4

  22. Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2000 cited by 422

  23. Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

    Authors: , , , , , , , , , , , - Blood 1996 cited by 417

  24. Prognostic significance of survivin expression in diffuse large B-cell lymphomas.

    Authors: , , , , , , , , , , , , - 2000 cited by 360